Inter-arm differences in blood pressure: when are they clinically significant?

PubWeight™: 2.34‹?› | Rank: Top 2%

🔗 View Article (PMID 12023677)

Published in J Hypertens on June 01, 2002

Authors

Deirdre Lane1, Michele Beevers, Nicola Barnes, James Bourne, Andrew John, Simon Malins, D Gareth Beevers

Author Affiliations

1: University Department of Medicine, City Hospital, Birmingham, UK.

Articles citing this

The difference in blood pressure readings between arms and survival: primary care cohort study. BMJ (2012) 2.56

Blood pressure measurement guidelines for physical therapists. Cardiopulm Phys Ther J (2011) 1.53

Relationship between inter-arm difference in systolic blood pressure and arterial stiffness in community-dwelling older adults. J Clin Hypertens (Greenwich) (2013) 1.51

Accurate blood pressure measurements and the other arm: the doctor is ultimately responsible. Tex Heart Inst J (2013) 1.40

Inter-arm blood pressure differences compared with ambulatory monitoring: a manifestation of the 'white-coat' effect? Br J Gen Pract (2013) 1.26

The epidemiology of subclavian stenosis and its association with markers of subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA). Atherosclerosis (2010) 1.09

Inter-arm blood pressure difference in type 2 diabetes: a barrier to effective management? Br J Gen Pract (2009) 1.05

Association of interarm systolic blood pressure difference with atherosclerosis and left ventricular hypertrophy. PLoS One (2012) 0.99

Blood pressure should be measured in both arms on the first consultation. J Hypertens (2002) 0.92

Blood pressure variability and cardiovascular disease: systematic review and meta-analysis. BMJ (2016) 0.91

The systolic blood pressure difference between arms and cardiovascular disease in the Framingham Heart Study. Am J Med (2013) 0.87

Blood pressure monitoring technique impacts hypertension treatment. J Gen Intern Med (2011) 0.87

Considerations for SphygmoCor radial artery pulse wave analysis: side selection and peripheral arterial blood pressure calibration. Hypertens Res (2015) 0.86

Hypertension and mortality in the Golestan Cohort Study: A prospective study of 50 000 adults in Iran. J Hum Hypertens (2015) 0.83

A relative difference in systolic blood pressure between arms by synchronal measurement and conventional cardiovascular risk factors are associated with the severity of coronary atherosclerosis. Heart Vessels (2015) 0.83

Inter-arm blood pressure difference and mortality: a cohort study in an asymptomatic primary care population at elevated cardiovascular risk. Br J Gen Pract (2016) 0.81

Impact of weight loss on ankle-brachial index and interartery blood pressures. Obesity (Silver Spring) (2014) 0.76

Bilateral subclavian artery stenosis found by inter-arm blood pressure difference during distal pancreatectomy. Korean J Anesthesiol (2013) 0.75

Percutaneous treatment of refractory angina secondary to left subclavian artery stenosis in patients after coronary artery bypass grafting. Arq Bras Cardiol (2013) 0.75

Prevalence of systolic inter-arm differences in blood pressure for different primary care populations: systematic review and meta-analysis. Br J Gen Pract (2016) 0.75

Short-term blood pressure variability - variation between arm side, body position and successive measurements: a population-based cohort study. BMC Cardiovasc Disord (2017) 0.75

Modalities of Invasive Arterial Pressure Monitoring in Critically Ill Patients: A Prospective Observational Study. Medicine (Baltimore) (2015) 0.75

Significant interarm blood pressure difference predicts cardiovascular risk in hypertensive patients: CoCoNet study. Medicine (Baltimore) (2016) 0.75

Sources of inaccuracy in the measurement of adult patients' resting blood pressure in clinical settings: a systematic review. J Hypertens (2016) 0.75

Prevalence of inter-arm blood pressure difference among clinical out-patients. Int J Health Sci (Qassim) (2016) 0.75

Articles by these authors

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet (2005) 12.92

Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA). Lancet (2005) 2.37

Low-dose spironolactone in the management of resistant hypertension: a surveillance study. J Hypertens (2007) 2.35

Persistent macrovascular and microvascular dysfunction in patients with malignant hypertension. Hypertension (2011) 1.55

Lack of impact of pulse pressure on outcomes in patients with malignant phase hypertension: the West Birmingham Malignant Hypertension study. J Hypertens (2012) 1.51

A naturalistic study of galantamine for Alzheimer's disease. CNS Drugs (2006) 1.51

Ethnic differences in cardiovascular and all-cause mortality in Birmingham, England: the Birmingham Factory Screening Project. J Hypertens (2005) 1.46

Self-care and adherence to medication: a survey in the hypertension outpatient clinic. BMC Complement Altern Med (2008) 1.44

Long-term effects of non-linear frequency compression for children with moderate hearing loss. Int J Audiol (2011) 1.29

Evaluation of nonlinear frequency compression for school-age children with moderate to moderately severe hearing loss. J Am Acad Audiol (2011) 1.29

Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). J Am Coll Cardiol (2004) 1.27

The prevalence and persistence of depression and anxiety following myocardial infarction. Br J Health Psychol (2002) 1.11

Endothelial damage and angiogenesis in hypertensive patients: relationship to cardiovascular risk factors and risk factor management. Am J Hypertens (2003) 1.00

In-hospital symptoms of depression do not predict mortality 3 years after myocardial infarction. Int J Epidemiol (2002) 1.00

beta-Blockers in hypertension-the emperor has no clothes: an open letter to present and prospective drafters of new guidelines for the treatment of hypertension. Am J Hypertens (2003) 0.98

Circulating matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases-1 and -2 levels in gestational hypertension. Am J Hypertens (2005) 0.96

Von Willebrand factor, soluble P-selectin, and target organ damage in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). Hypertension (2002) 0.96

Management of hypertension in ethnic minorities. Heart (2005) 0.96

Anti-hypertensive drugs in pregnancy and fetal growth: evidence for "pharmacological programming" in the first trimester? Hypertens Pregnancy (2002) 0.94

Improving survival of malignant hypertension patients over 40 years. Am J Hypertens (2009) 0.94

Upregulation of EphA4 on astrocytes potentially mediates astrocytic gliosis after cortical lesion in the marmoset monkey. J Neurotrauma (2010) 0.92

Relation of thrombogenesis in systemic hypertension to angiogenesis and endothelial damage/dysfunction (a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial [ASCOT]). Am J Cardiol (2003) 0.91

Amiloride 10 mg is less effective than spironolactone 25 mg in patients with hypertension resistant to a multidrug regime including an angiotensin-blocking agent. J Hypertens (2007) 0.88

The effect of front-end processing on cochlear implant performance of children. Otol Neurotol (2011) 0.87

Hormone replacement therapy and arterial blood pressure in postmenopausal women with hypertension. Blood Press (2005) 0.85

Naturalistic treatment of Alzheimer's disease with galantamine: 12-month follow-up from the NATURE study. CNS Drugs (2007) 0.84

Alcohol and cardiovascular disease--more than one paradox to consider. Alcohol and hypertension--does it matter? (no!). J Cardiovasc Risk (2003) 0.82

Hypertension, left ventricular hypertrophy, and sudden death. Curr Cardiol Rep (2002) 0.82

Effects of input processing and type of personal frequency modulation system on speech-recognition performance of adults with cochlear implants. Ear Hear (2012) 0.82

Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers safe in pregnancy: a report of ninety-one pregnancies. J Hypertens (2011) 0.80

Evaluation of speech recognition of cochlear implant recipients using a personal digital adaptive radio frequency system. J Am Acad Audiol (2013) 0.79

Screening for aortic coarctation by comparing blood pressure in the arms and legs is more convenient and reliable than examination of the femoral pulses. J Hypertens (2011) 0.79

Effects of losartan versus hydrochlorothiazide on indices of endothelial damage/dysfunction, angiogenesis and tissue factor in essential hypertension. Blood Press (2004) 0.79

A comprehensive assessment of cardiac structure and function in patients with treated malignant phase hypertension: the West Birmingham Malignant Hypertension project. Int J Cardiol (2011) 0.78

Circulating endothelial cells, arterial stiffness, and cardiovascular risk stratification in hypertension. Chest (2007) 0.78

Low-density lipoprotein subfractions and cardiovascular risk in hypertension: relationship to endothelial dysfunction and effects of treatment. Hypertension (2003) 0.78

Hypertension in ethnic groups: epidemiological and clinical perspectives. Expert Rev Cardiovasc Ther (2009) 0.78

Evaluation of wideband frequency responses and non-linear frequency compression for children with mild to moderate high-frequency hearing loss. Int J Audiol (2015) 0.77

Evaluation of Performance With an Adaptive Digital Remote Microphone System and a Digital Remote Microphone Audio-Streaming Accessory System. Am J Audiol (2015) 0.76

Hypertension and renal failure. Clin Med (2002) 0.76

Does obesity influence target organ damage and outcomes in patients with malignant phase hypertension? The West Birmingham Malignant Hypertension Project. Hypertens Res (2013) 0.75

Ethnic disparities in malignant hypertension: further observations. J Hypertens (2007) 0.75

Delay in the diagnosis of Conn's syndrome: a single-center experience over 30 years. Hypertension (2008) 0.75

S100-Negative, CD1a-Positive Cutaneous Histiocytosis in a Patient with S100-Positive, CD1a-Positive Pulmonary Histiocytosis. Am J Dermatopathol (2015) 0.75

Using practitioners' feedback to contribute to organisational development in health visiting. Community Pract (2014) 0.75

Primary hyperaldosteronism. Ann Clin Biochem (2003) 0.75

Atrial fibrillation in primary aldosteronism. J Renin Angiotensin Aldosterone Syst (2009) 0.75

Predictors of 5-year outcomes in malignant phase hypertension: the West Birmingham Malignant Hypertension Registry. J Hypertens (2017) 0.75

Future characteristics of bypassing agents to improve care of hemophilia inhibitor patients: an economic and health-related quality of life perspective. Expert Rev Pharmacoecon Outcomes Res (2011) 0.75

Soluble Fas and Fas ligand in pregnancy: influence of hypertension. Angiology (2011) 0.75

Angiogenin and hemoxygenase in pregnancy: influence of hypertension. Angiology (2011) 0.75

Will adherence to new guidance lead to missed cancer diagnoses? Evaluation of limiting symptomatic mammograms to over forties. Breast J (2013) 0.75